Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,648 | 9 | 92.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,068 | 4 | 7.5% |
| Food and Beverage | $106.69 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Partner Therapeutics, Inc. | $33,961 | 7 | $0 (2022) |
| Merck Sharp & Dohme LLC | $6,775 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $86.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,300 | 1 | Merck Sharp & Dohme LLC ($1,300) |
| 2023 | $1,300 | 1 | Merck Sharp & Dohme LLC ($1,300) |
| 2022 | $595.09 | 3 | Merck Sharp & Dohme LLC ($500.00) |
| 2021 | $1,098 | 2 | Partner Therapeutics, Inc. ($1,098) |
| 2020 | $26,473 | 3 | Partner Therapeutics, Inc. ($25,248) |
| 2019 | $1,245 | 2 | Merck Sharp & Dohme Corporation ($1,225) |
| 2018 | $8,725 | 2 | Partner Therapeutics, Inc. ($7,500) |
| 2017 | $86.67 | 1 | GlaxoSmithKline, LLC. ($86.67) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 03/06/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 06/27/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 03/07/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 02/22/2022 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $95.09 | General |
| Category: Hematology/Oncology | ||||||
| 08/17/2021 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $737.50 | General |
| Category: Hematology/Oncology | ||||||
| 08/01/2021 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $360.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/01/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,225.00 | General |
| 04/02/2020 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,875.00 | General |
| Category: Hematology | ||||||
| 01/22/2020 | Partner Therapeutics, Inc. | Leukine (Drug) | Consulting Fee | Cash or cash equivalent | $23,373.00 | General |
| Category: Hematology | ||||||
| 12/08/2019 | Partner Therapeutics, Inc. | Leukine (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Hematology | ||||||
| 10/04/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,225.00 | General |
| 10/15/2018 | Partner Therapeutics, Inc. | Leukine (Drug) | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| Category: Hematology | ||||||
| 10/02/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,225.00 | General |
| 12/10/2017 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $86.67 | General |
About Robert Gale
Robert Gale is a Medical Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2009. The National Provider Identifier (NPI) number assigned to this provider is 1003057654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Gale has received a total of $40,822 in payments from pharmaceutical and medical device companies, with $1,300 received in 2024. These payments were reported across 15 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($37,648).
Practice Information
- Specialty Medical Oncology
- Location Los Angeles, CA
- Active Since 03/11/2009
- Last Updated 03/11/2009
- Taxonomy Code 207RX0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003057654
Products in Payments
- Leukine (Drug) $33,961
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Los Angeles
Dr. Jacek Pinski, M.d, M.D
Medical Oncology — Payments: $882,931
Stephen Liu, Md, MD
Medical Oncology — Payments: $792,850
Matthew Rettig, Md, MD
Medical Oncology — Payments: $564,294
Mark Agulnik, Md, MD
Medical Oncology — Payments: $414,988
Dr. David Quinn, M.d, M.D
Medical Oncology — Payments: $304,638
Dr. David Tran, Md Phd, MD PHD
Medical Oncology — Payments: $131,074